Optimizing outcomes for renal artery intervention

Circulation: Cardiovascular Interventions

Volumn 3, Issue 2, 2010, Pages 184-192

  White, Christopher J ^a  

^a NONE

Author keywords

Hypertension; Ischemic nephropathy; Kidney; Renal; Renal angioplasty; Renovascular hypertension; Stents

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; RENIN;

ANGIOPLASTY; CLINICAL TRIAL; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY EMBOLISM; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; STENT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; CATHETERIZATION; HUMANS; HYPERTENSION, RENOVASCULAR; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; TREATMENT OUTCOME;

EID: 77953667520     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.109.910208     Document Type: Review

References (78)

1. White CJ. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation. 2006;113:1464-1473.
2. Safian RD, Madder RD. Refining the approach to renal artery revascularization. J Am Coll Cardiol Cardiovasc Interv. 2009;2:161-174.
3. Mukherjee D. Renal artery revascularization: is there a rationale to perform? J Am Coll Cardiol Cardiovasc Interv. 2009;2:183-184.
4. Textor SC, Lerman L, McKusick M. The uncertain value of renal artery interventions: where are we now? J Am Coll Cardiol Cardiovasc Interv. 2009;2:175-182.
5. Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR, Short RA, Henneberry KJ, Dunham LA, Raabe RD. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent. Am J Kidney Dis. 1998;32:611-622.
6. Rocha-Singh KJ, Mishkel GJ, Katholi RE, Ligon RA, Armbruster JA, McShane KJ, Zeck KJ. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv. 1999;47:167-172.
7. Blum U, Krumme B, Flugel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, Schollmeyer P, Langer M. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty [see comments]. N Engl J Med. 1997;336:459-465. (Pubitemid 27074356)
8. White CJ, Ramee SR, Collins TJ, Jenkins JS, Escobar A, Shaw D. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445-1450.
9. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647. (Pubitemid 28387490)
10. Ivanovic V, McKusick MA, Johnson CM III, Sabater EA, Andrews JC, Breen JF, Bjarnason H, Misra S, Stanson AW. Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol. 2003;14:217-225.
11. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn HP, Cook-Bruns N, Neumann F. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249. (Pubitemid 37363042)
12. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Quart J Med. 1999;92:159-167.
13. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J, Man In't Veld AJ. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78-85.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. (Pubitemid 37553153)
15. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113: e463-e654.
16. Subramanian R, White CJ, Rosenfield K, Bashir R, Almagor Y, Meerkin D, Shalman E. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc Interv. 2005;64:480-486.
17. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333-2342.
18. Mulumudi MS, White CJ. Renal frame count: a quantitative angiographic assessment of renal perfusion. Catheter Cardiovasc Interv. 2005;65:183-186.
19. Mahmud E, Smith TW, Palakodeti V, Zaidi O, Ang L, Mitchell CR, Zafar N, Bromberg-Marin G, Keramati S, Tsimikas S. Renal frame count and renal blush grade: quantitative measures that predict the success of renal stenting in hypertensive patients with renal artery stenosis. J Am Coll Cardiol Cardiovasc Interv. 2008;1:286-292.
20. Maxwell MH, Rudnick MR, Waks AU. New approaches to the diagnosis of renovascular hypertension. Adv Nephrol Necker Hosp. 1985;14:285-304.
21. De Bruyne B, Manoharan G, Pijls NH, Verhamme K, Madaric J, Bartunek J, Vanderheyden M, Heyndrickx GR. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851-1855.
22. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
23. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202-209.
24. ten Wolde M, Tulevski II, Mulder JW, Sohne M, Boomsma F, Mulder BJ, Buller HR. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation. 2003;107:2082-2084.
25. Silva JA, Chan AW, White CJ, Collins TJ, Jenkins JS, Reilly JP, Ramee SR. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111:328-333.
26. Rastan A, Krankenberg H, Muller-Hulsbeck S, Sixt S, Tubler T, Muller C, Schwarzwalder U, Frank U, Schwarz T, Leppaenen O, Neumann FJ, Zeller T. Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION). Euro Intervention. 2008;4:208-213.
27. Mitchell J, Subramanian R, White C, Soukas P, Almagor Y, Stewart R, Rosenfield K. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement. Catheter Cardiovasc Interv. 2007;69:685-689.
28. Leesar MA, Varma J, Shapira A, Fahsah I, Raza ST, Elghoul Z, Leonard AC, Meganathan K, Ikram S. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363-2371.
29. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
30. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18:2644-2648.
31. Harden P, MacLeod M, Rodger R, Baxter G, Connell J, Dominiczak A, Junor B, Briggs J, Moss J. Effect of renal artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
32. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712-719.
33. Watson P, Hadjipetrou P, Cox S, Piemonte T, Eisenhauer A. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
34. Muray S, Martin M, Amoedo M, Garcia C, Jornet A, Vera M, Oliverae A, Gomez X, Craver L, Real M, Garcia L, Botey A, Montanya X, Fernandez
35. E. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002;39:60-66.
36. Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, Mali WP. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol. 2001;12:1475-1481.
37. Dejani H, Eisen TD, Finkelstein FO. Revascularization of renal artery stenosis in patients with renal insufficiency. Am J Kidney Dis. 2000;36:752-758.
38. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol. 2004;15:1974-1982.
39. Bax L, Algra A, Mali WP, Edlinger M, Beutler JJ, van der Graaf Y. Renal function as a risk indicator for cardiovascular events in 3216 patients with manifest arterial disease. Atherosclerosis. 2008;200:184-190.
40. van Jaarsveld B, Krijnen P, Pieterman H, Derkx F, Deinum J, Postma C, Dees A, Woittiez A, Bartelink A, Man in't Veld A, Schalekamp M. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Eng J Med. 2000;342:1007-1014.
41. White C. Fight the stupids! Catheter Cardiovasc Interv. 2009;74:530-532.
42. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-1962.
43. Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, Rastan A, Zeller T. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv. 2010;75:1-10.
44. Kalra P, Green D, Cheung CM, Chrysochou C, Sixt S, Rastan A, Zeller T. Medical therapy versus primary renal artery stenting-a twin centre study of outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant. 2007;22:vi(A).
45. Rivolta R, Bazzi C, Stradiotti P, Paparella M. Stenting of renal artery stenosis: is it beneficial in chronic renal failure? J Nephrol. 2005;18:749-754.
46. Chrysochou C, Cheung CM, Durow M, Middleton RJ, Solomon LR, Craig A, Venning M, Kalra PA. Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD). QJM. 2009;102:283-288.
47. Coen G, Moscaritolo E, Catalano C, Lavini R, Nofroni I, Ronga G, Sardella D, Zaccaria A, Cianci R. Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stenting. BMC Nephrol. 2004;5:15.
48. Marone LK, Clouse WD, Dorer DJ, Brewster DC, Lamuraglia GM, Watkins MT, Kwolek CJ, Cambria RP. Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease. J Vasc Surg. 2004;39:322-329.
49. La Batide-Alanore A, Azizi M, Froissart M, Raynaud A, Plouin PF. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol. 2001;12:1235-1241.
50. Leertouwer TC, Derkx FH, Pattynama PM, Deinum J, van Dijk LC, Schalekamp MA. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int. 2002;62:574-579.
51. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
52. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.
53. Cooper C, Haller S, Colyer W, Steffes M, Burket MW, Thomas WJ, Safian R, Reddy BK, Brewster PS, Ankenbrandt M, Virmani R, Dippel EJ, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapiro JI, D'Agostino R, Pencina MJ, Khuder SA. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117:2752-2760.
54. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol. 1997;29:1269-1275.
55. Kessel DO, Robertson I, Taylor EJ, Patel JV. Renal stenting from the radial artery: a novel approach. Cardiovasc Intervent Radiol. 2003;26:146-149.
56. Trani C, Tommasino A, Burzotta F. Transradial renal stenting: why and how. Catheter Cardiovasc Interv. 2009;74:951-956.
57. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med. 1957;257:442-447.
58. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol. 2001;12:1781-1787.
59. Scolari F, Ravani P, Pola A, Guerini S, Zubani R, Movilli E, Savoldi S, Malberti F, Maiorca R. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol. 2003;14:1584-1590.
60. Scoble JE. Do protection devices have a role in renal angioplasty and stent placement? Nephrol Dial Transplant. 2003;18:1700-1703.
61. Henry M, Klonaris C, Henry I, Tzetanov K, Le Borgne E, Foliguet B, Hugel M. Protected renal stenting with the Percu Surge Guard Wire device: a pilot study. J Endovasc Ther. 2001;8:227-237.
62. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G, Rajacopal S, Hugel M. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv. 2003;60:299-312.
63. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38:962-968.
64. Henry M, Henry I, Polydorou A, Rajagopal S, Lakshmi G, Hugel M. Renal angioplasty and stenting: long-term results and the potential role of protection devices. Expert Rev Cardiovasc Ther. 2005;3:321-334.
65. Hagspiel KD, Stone JR, Leung DA. Renal angioplasty and stent placement with distal protection: preliminary experience with the Filter Wire EX. J Vasc Interv Radiol. 2005;16:125-131.
66. Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J, Geary RL, Hansen KJ. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg. 2006;44:128-135.
67. Holden A, Hill A, Jaff MR, Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int. 2006;70:948-955.
68. Edwards MS, Corriere MA, Craven TE, Pan XM, Rapp JH, Pearce JD, Mertaugh NB, Hansen KJ. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg. 2007;46:55-61.
69. Henry M, Henry I, Polydorou A, Hugel M. Embolic protection for renal artery stenting. J Cardiovasc Surg (Torino). 2008;49:571-589.
70. Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc Interv. 1999;46:245-248.
71. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 2001;104:1999-2002. (Pubitemid 33027036)
72. Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg. 2005;41:1026-1030.
73. Clarification on billing requirements for percutaneous transluminal angioplasty (PTA) concurrent with the placement of an investigational or FDA-approved carotid stent. Available at: http://www.cms.hhs.gov/transmittals/ downloads/R53ncdpdf. Accessed March 22, 2010.
74. Deleted in proof.
75. Topol EJ, Lincoff AM, Kereiakes DJ, Kleiman NS, Cohen EA, Ferguson JJ, Tcheng JE, Sapp S, Califf RM. Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. Am J Med. 2002;113:1-6.
76. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002;106:3063-3067.
77. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-1290.
78. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548-553.